|
|
|||||||||||
The British Journal of Psychiatry 153: 232-235 (1988)
© 1988 The Royal College of Psychiatrists
GA Sampson, PR Heathcote, J Wordsworth, P Prescott and A Hodgson
Whiteley Wood Clinic, Sheffield.
A double-blind, cross-over, placebo-controlled study of dydrogesterone (10 mg b.d.) in the treatment of premenstrual syndrome is described. Two groups of women were studied: secondarily referred hospital clinic patients, and self-referred patients. Only one-third of patients screened completed the study. All patients showed significant improvements in symptom scores during the course of the study, the only significant difference between placebo- and dydrogesterone-treated patients being an increase in frequency of breast tenderness and a decrease in pain with menstrual bleeding in the latter.
This article has been cited by other articles:
![]() |
K. Wyatt, P. Dimmock, P. Jones, M. Obhrai, and S. O'Brien Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review BMJ, October 6, 2001; 323(7316): 776 - 776. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |